Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?

Brennan, A.T., Davies, M.-A., Bor, J. , Wandeler, G., Stinson, K., Wood, R., Prozesky, H., Tanser, F., Fatti, G., Boulle, A., Sikazwe, I., Wool-Kaloustian, K., Yuannoutsos, C., Leroy, V., De Rekeneire, N. and Fox, M.P. (2017) Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? AIDS, 31 (1). pp. 147-157.

Full content URL: https://www2.scopus.com/inward/record.uri?eid=2-s2...

Full text not available from this repository.

Item Type:Article
Item Status:Live Archive

Additional Information:cited By 4
ID Code:37589
Deposited On:09 Oct 2019 15:42

Repository Staff Only: item control page